pharma news today glp-1 obesity Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Weight-loss drugs could boost US

For patients with thyroid disease, particular attention should be paid to thyroid function monitoring, as weight changes may influence thyroid hormone requirements

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), a category of antidiabetic medications such as semaglutide and liraglutide, have dramatically improved outcomes in the treatment of T2D and obesity, significantly reducing complications from their metabolic consequences including cardiovascular and chronic kidney disease [20, 21]

It is conceivable that metformin may be able to potentiate or strengthen the vascular protective effects of GLP-1 and its analogues

Begin Your New Chapter

Take 1 capsule daily, best taken at night before bed

& Poulsen, J